Our Long-term Vision and Pioneering Attitude
The pharmaceutical industry is undergoing major changes, challenging the way manufacturers approach the safety and quality of treatments for patients. Our ambition is to be recognized as the partner of choice for smart quality control of manufacturers around the globe, targeting both patient safety and customer productivity.
What has set us apart as a trusted reference for worldwide leaders in the pharmaceutical sector for over 60 years?
- Our passionate team members, who are present in more than 100 countries
- Our unrivaled investment in innovation
- The rigorous science behind our quality control promise
Our Commitment to Our Customers
Monitoring quality in microbiology is critical and challenging for pharmaceutical companies. While hand transcription remains the standard procedure in use, these daily processes often rhyme with errors leading to time-consuming investigations, and not fully compliant data.
Environmental monitoring (EM) is the main microbiological control performed by pharmaceutical industries. While multiple hand-written and transcription operations remain the standard procedure in use for thousands of samples per month, the daily processes often result in errors leading to time-consuming investigations, low value-added tasks and data that is not fully compliant. As a result: major impacts on batch release, on process efficiency and ultimately patient safety.
The 3P® legacy is one of delivering proven performance when it comes to effective pharmaceutical contamination control. Now it’s going digital.
AIR IDEAL® 3P® is used for the detection of viable organisms through active air sampling.
API® makes microbial identification simple and reliable. Combining a standardized method with an extensive and robust digital microbial ID knowledge base, API® can easily be implemented into any microbiology laboratory.